1. SchultzH (1998) Tobacco or health: A global status report. Ann Saudi Med 18: 195.
2. WHO urges more countries to require large, graphic health warnings on tobacco packaging: the WHO report on the global tobacco epidemic, 2011 examines anti-tobacco mass-media campaigns. Cent Eur J Public Health 19: 133, 151.
3. FlintermanLE, van HylckamaVA, CannegieterSC, RosendaalFR (2012) Long-term survival in a large cohort of patients with venous thrombosis: incidence and predictors. PLoS Med 9: e1001155 doi:10.1371/journal.pmed.1001155
4. CushmanM, TsaiAW, WhiteRH, HeckbertSR, RosamondWD, et al. (2004) Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 117: 19–25.
5. LindbladB, SternbyNH, BergqvistD (1991) Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ 302: 709–711.
6. TavoraF, CrowderC, KutysR, BurkeA (2008) Discrepancies in initial death certificate diagnoses in sudden unexpected out-of-hospital deaths: the role of cardiovascular autopsy. Cardiovasc Pathol 17: 178–182.
7. HolstAG, JensenG, PrescottE (2010) Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation 121: 1896–1903.
8. SeverinsenMT, KristensenSR, JohnsenSP, DethlefsenC, TjonnelandA, et al. (2009) Smoking and venous thromboembolism: a Danish follow-up study. J Thromb Haemost 7: 1297–1303.
9. RosengrenA, FredenM, HanssonPO, WilhelmsenL, WedelH, et al. (2008) Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men. J Thromb Haemost 6: 558–564.
10. TsaiAW, CushmanM, RosamondWD, HeckbertSR, PolakJF, et al. (2002) Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med 162: 1182–1189.
11. AgenoW, BecattiniC, BrightonT, SelbyR, KamphuisenPW (2008) Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 117: 93–102.
12. GreenlandS (1987) Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9: 1–30.
13. HigginsJP, ThompsonSG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539–1558.
14. LEVINML (1953) The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum 9: 531–541.
15. van HouwelingenHC, ArendsLR, StijnenT (2002) Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 21: 589–624.
16. GreenlandS, LongneckerMP (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135: 1301–1309.
17. MillerJJ (1978) The inverse of the Freeman-Turkey double arcsine transformation. Am Stat 32: 138.
18. EggerM, DaveySG, SchneiderM, MinderC (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629–634.
19. GoldhaberSZ, GrodsteinF, StampferMJ, MansonJE, ColditzGA, et al. (1997) A prospective study of risk factors for pulmonary embolism in women. JAMA 277: 642–645.
20. HanssonPO, ErikssonH, WelinL, SvardsuddK, WilhelmsenL (1999) Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: “the study of men born in 1913”. Arch Intern Med 159: 1886–1890.
21. KlatskyAL, ArmstrongMA, PoggiJ (2000) Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol 85: 1334–1337.
22. GlynnRJ, RosnerB (2005) Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 162: 975–982.
23. LindqvistPG, EpsteinE, OlssonH (2009) The relationship between lifestyle factors and venous thromboembolism among women: a report from the MISS study. Br J Haematol 144: 234–240.
24. RosengrenA, FredenM, HanssonPO, WilhelmsenL, WedelH, et al. (2008) Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men. J Thromb Haemost 6: 558–564.
25. LutseyPL, VirnigBA, DurhamSB, SteffenLM, HirschAT, et al. (2010) Correlates and consequences of venous thromboembolism: The Iowa Women's Health Study. Am J Public Health 100: 1506–1513.
26. Hippisley-CoxJ, CouplandC (2011) Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study. BMJ 343: d4656.
27. EngaKF, BraekkanSK, Hansen-KroneIJ, le CessieS, RosendaalFR, et al. (2012) Cigarette smoking and the risk of venous thromboembolism: The Tromso Study. J Thromb Haemost 10: 2068–2074.
28. WattanakitK, LutseyPL, BellEJ, GornikH, CushmanM, et al. (2012) Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A time-dependent analysis. Thromb Haemost 108: 508–515.
29. SweetlandS, ParkinL, BalkwillA, GreenJ, ReevesG, et al. (2013) Smoking, surgery, and venous thromboembolism risk in women: United Kingdom cohort study. Circulation 127: 1276–1282.
30. DreyerNA, PizzoSV (1980) Blood coagulation and idiopathic thromboembolism among fertile women. Contraception 22: 123–135.
31. LuY, HuiR, ZhaoY (2001) [Insertion/deletion polymorphsim of the angiotensin I converting enzyme gene and pulmonary thromboembolism in Chinese population]. Zhonghua Jie He He Hu Xi Za Zhi 24: 265–268.
32. RayJG, LangmanLJ, VermeulenMJ, EvrovskiJ, YeoEL, et al. (2001) Genetics University of Toronto Thrombophilia Study in Women (GUTTSI): genetic and other risk factors for venous thromboembolism in women. Curr Control Trials Cardiovasc Med 2: 141–149.
33. TosettoA, FrezzatoM, RodeghieroF (2003) Prevalence and risk factors of non-fatal venous thromboembolism in the active population of the VITA Project. J Thromb Haemost 1: 1724–1729.
34. WorralurtC, TaneepanichskulS (2005) Risk factors of venous thromboembolism (VTE) in Thai reproductive aged female: King Chulalongkorn Memorial Hospital experience. J Med Assoc Thai 88: 1502–1505.
35. HirohashiT, YoshinagaK, SakuraiT, KanaiM, ShimizuK, et al. (2006) [Study of the echocardiographic diagnosis of acute pulmonary thromboembolism and risk factors for venous thromboembolism]. J Cardiol 47: 63–71.
36. SugimuraK, SakumaM, ShiratoK (2006) Potential risk factors and incidence of pulmonary thromboembolism in Japan: results from an overview of mailed questionnaires and matched case-control study. Circ J 70: 542–547.
37. PompER, RosendaalFR, DoggenCJ (2008) Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. Am J Hematol 83: 97–102.
38. PrandoniP, BiloraF, MarchioriA, BernardiE, PetrobelliF, et al. (2003) An association between atherosclerosis and venous thrombosis. N Engl J Med 348: 1435–1441.
39. JangMJ, ChoiWI, BangSM, LeeT, KimYK, et al. (2009) Metabolic syndrome is associated with venous thromboembolism in the Korean population. Arterioscler Thromb Vasc Biol 29: 311–315.
40. YamadaN, OtaS, LiuY, CraneMM, ChangCM, et al. (2010) Risk factors for nonfatal pulmonary embolism in a Japanese population: a hospital-based case-control study. Angiology 61: 269–274.
41. BhoopatL, RojnuckarinP, HiransuthikulN, IntragumtornchaiT (2010) Low vegetable intake is strongly associated with venous thromboembolism in Thai population. Blood Coagul Fibrinolysis 21: 758–763.
42. Quist-PaulsenP, NaessIA, CannegieterSC, RomundstadPR, ChristiansenSC, et al. (2010) Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2). Haematologica 95: 119–125.
43. ZhuJ, ZhengWJ, KongFC, ZhangWJ, WangHY, et al. (2010) CYP1A1, smoking and venous thromboembolism. Thromb Haemost 104: 702–708.
44. CayN, IpekA, GumusM, BirkanZ, OzmenE (2012) Platelet activity indices in patients with deep vein thrombosis. Clin Appl Thromb Hemost 18: 206–210.
45. Di MinnoMN, TufanoA, GuidaA, Di CapuaM, De GregorioAM, et al. (2011) Abnormally high prevalence of major components of the metabolic syndrome in subjects with early-onset idiopathic venous thromboembolism. Thromb Res 127: 193–197.
46. AbudurehemanK, MahemutiA, XiaYN, HuXM (2012) [Association between gene polymorphisms of methylenetetrahydrofolate reductase and plasma homocysteine in Uygur patients with venous thromboembolism]. Zhonghua Xin Xue Guan Bing Za Zhi 40: 1030–1036.
47. CilH, YavuzC, IslamogluY, TekbasEO, DemirtasS, et al. (2012) Platelet count and mean platelet volume in patients with in-hospital deep venous thrombosis. Clin Appl Thromb Hemost 18: 650–653.
48. BlondonM, WigginsKL, McKnightB, PsatyBM, RiceKM, et al. (2013) The association of smoking with venous thrombosis in women. A population-based, case-control study. Thromb Haemost 109.
49. ParkinL, SweetlandS, BalkwillA, GreenJ, ReevesG, et al. (2012) Body mass index, surgery, and risk of venous thromboembolism in middle-aged women: a cohort study. Circulation 125: 1897–1904.
50. SchmidtM, JohannesdottirSA, LemeshowS, LashTL, UlrichsenSP, et al. (2013) Obesity in young men, and individual and combined risks of type 2 diabetes, cardiovascular morbidity and death before 55 years of age: a Danish 33-year follow-up study. BMJ Open 3: e002698.
51. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 346: 1575–1582.
52. SultanAA, TataLJ, WestJ, FiaschiL, FlemingKM, et al. (2013) Risk factors for first venous thromboembolism around pregnancy: a population-based cohort study from the United Kingdom. Blood 121: 3953–3961.
53. KawasakiT, KambayashiJ, AriyoshiH, SakonM, SuehisaE, et al. (1997) Hypercholesterolemia as a risk factor for deep-vein thrombosis. Thromb Res 88: 67–73.
54. HorstedF, WestJ, GraingeMJ (2012) Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med 9: e1001275 doi:10.1371/journal.pmed.1001275
55. JanuelJM, ChenG, RuffieuxC, QuanH, DouketisJD, et al. (2012) Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review. JAMA 307: 294–303.
56. ScarabinPY, OgerE, Plu-BureauG (2003) Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet 362: 428–432.
57. SegalJB, BrotmanDJ, NecocheaAJ, EmadiA, SamalL, et al. (2009) Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review. JAMA 301: 2472–2485.
58. SeverinsenMT, OvervadK, JohnsenSP, DethlefsenC, MadsenPH, et al. (2010) Genetic susceptibility, smoking, obesity and risk of venous thromboembolism. Br J Haematol 149: 273–279.
59. LeeKW, LipGY (2003) Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med 163: 2368–2392.
60. MillerGJ, BauerKA, CooperJA, RosenbergRD (1998) Activation of the coagulant pathway in cigarette smokers. Thromb Haemost 79: 549–553.
61. YarnellJW, SweetnamPM, RumleyA, LoweGD (2000) Lifestyle and hemostatic risk factors for ischemic heart disease: the Caerphilly Study. Arterioscler Thromb Vasc Biol 20: 271–279.
62. OgerE, LacutK, Van DredenP, BressolletteL, AbgrallJF, et al. (2003) High plasma concentration of factor VIII coagulant is also a risk factor for venous thromboembolism in the elderly. Haematologica 88: 465–469.
63. FeherMD, RamplingMW, BrownJ, RobinsonR, RichmondW, et al. (1990) Acute changes in atherogenic and thrombogenic factors with cessation of smoking. J R Soc Med 83: 146–148.
64. BakhruA, ErlingerTP (2005) Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey. PLoS Med 2: e160 doi:10.1371/journal.pmed.0020160
65. YarnellJW, SweetnamPM, RumleyA, LoweGD (2001) Lifestyle factors and coagulation activation markers: the Caerphilly Study. Blood Coagul Fibrinolysis 12: 721–728.
66. YukizawaY, InabaY, WatanabeS, YajimaS, KobayashiN, et al. (2012) Association between venous thromboembolism and plasma levels of both soluble fibrin and plasminogen-activator inhibitor 1 in 170 patients undergoing total hip arthroplasty. Acta Orthop 83: 14–21.
67. GaryT, HafnerF, FroehlichH, StojakovicT, ScharnaglH, et al. (2010) High factor VIII activity, high plasminogen activator inhibitor 1 antigen levels and low factor XII activity contribute to a thrombophilic tendency in elderly venous thromboembolism patients. Acta Haematol 124: 214–217.
68. WilliC, BodenmannP, GhaliWA, FarisPD, CornuzJ (2007) Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 298: 2654–2664.
69. YehJM, HurC, SchragD, KuntzKM, EzzatiM, et al. (2013) Contribution of H. pylori and smoking trends to US incidence of intestinal-type noncardia gastric adenocarcinoma: a microsimulation model. PLoS Med 10: e1001451 doi:10.1371/journal.pmed.1001451
70. KhawKT, FriesenMD, RiboliE, LubenR, WarehamN (2012) Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk prospective study. PLoS Med 9: e1001255.
71. LutseyPL, VirnigBA, DurhamSB, SteffenLM, HirschAT, et al. (2010) Correlates and consequences of venous thromboembolism: The Iowa Women's Health Study. Am J Public Health 100: 1506–1513.
72. GrumelliS, CorryDB, SongLZ, SongL, GreenL, et al. (2004) An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med 1: e8.
73. SchneiderC, BothnerU, JickSS, MeierCR (2010) Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol 25: 253–260.
74. GordonT, KannelWB, DawberTR, McGeeD (1975) Changes associated with quitting cigarette smoking: the Framingham Study. Am Heart J 90: 322–328.
75. Smoking wastes a good Parisienne. JAMA 262: 1185–1186.
76. AlbanesD, JonesDY, MicozziMS, MattsonME (1987) Associations between smoking and body weight in the US population: analysis of NHANES II. Am J Public Health 77: 439–444.
77. ShimokataH, MullerDC, AndresR (1989) Studies in the distribution of body fat. III. Effects of cigarette smoking. JAMA 261: 1169–1173.
78. CushmanM, KullerLH, PrenticeR, RodaboughRJ, PsatyBM, et al. (2004) Estrogen plus progestin and risk of venous thrombosis. JAMA 292: 1573–1580.